View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
March 1, 2021updated 21 Feb 2022 7:07am

Olympus exercises option to acquire Israel’s Medi-Tate

Olympus has exercised its option to acquire Israeli medical device company Medi-Tate to drive growth in its urology business and expand minimally invasive treatment product portfolio.

Olympus has exercised its option to acquire Israeli medical device company Medi-Tate to drive growth in its urology business and expand its minimally invasive treatment product portfolio.

Medi-Tate develops, manufactures, and markets benign prostatic hyperplasia (BPH) treatment devices for transurethral resection of the prostate (TURP) procedures, including resectoscopes, as well as a range of electrodes.

Olympus chief operating officer Nacho Abia said: “The investment in Medi-Tate has expanded our patient care offerings in BPH, adding to Olympus’ market-leading plasma resection portfolio for TURP.

“Our partnership with Medi-Tate has supported one of Olympus’ key strategic initiatives to drive growth in our urology business and to expand our minimally invasive surgical solutions, enabling further improvement of clinical outcomes, reduction of overall costs, and enhancement of patients’ quality of life and safety.”

In 2018, Olympus initially secured the rights to distribute Medi-Tate’s products, along with an option to acquire 100% of Medi-Tate later.

Medi-Tate’s leading product, iTind, is a temporarily implanted nitinol device that supports the relief of lower urinary tract symptoms (LUTS) due to BPH.

With EU CE Mark, the device is US Food and Drug Administration (FDA) cleared for use in the US and is approved for sale in the EU, UK, Israel, Australia, and Brazil.

Depending on the past two years’ iTind sales experience and clinical value of the product, Olympus has decided to exercise its option to acquire Medi-Tate to explore its potential in BPH treatment.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network